Handelsavisen
prelaunch
Companies Real Estate CHCT.K
CH
CHCT.K NYSE Health Care REITs

Community Healthcare Trust Inc

$18,82
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
10,02 %
Op margin
ROE
1,2 %
Net margin
4,2 %
Debt / equity
1,24
Beta
52w range
Volume
Day range
Prev close
$18,82
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Community Healthcare Trust Inc operates as a real estate investment trust that acquires and manages skilled nursing and rehabilitation facilities, generating revenue primarily through long-term net leases to third-party operators.

Business. Community Healthcare Trust Inc (CHCT.K) is a health care real estate investment trust (REIT) listed on the New York Stock Exchange. The company operates within the Real Estate sector, specifically focusing on the Health Care REITs industry. As segment and geographic breakdowns are not provided, the firm is described at the industry level as a specialized real estate entity. Its primary listing is identified by the ticker CHCT.K.

Classification85 %
SectorReal Estate
Industry groupHealth Care REITs
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
Nuveen LLC
largest disclosed fund holder
Profitability
1,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CHCT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate · THIS SECTOR−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CHCT.K. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Community Healthcare Trust Inc (CHCT.K) is a health care real estate investment trust (REIT) listed on the New York Stock Exchange. The company operates within the Real Estate sector, specifically focusing on the Health Care REITs industry. As segment and geographic breakdowns are not provided, the firm is described at the industry level as a specialized real estate entity. Its primary listing is identified by the ticker CHCT.K.

    Classification85 %
    SectorReal Estate
    Industry groupHealth Care REITs
    AI synthesis
    GENERATED

    Community Healthcare Trust Inc maintains a capital structure characterized by significant leverage, with a debt-to-equity ratio of 1.24. The balance sheet reflects total assets of $990.8 million against total liabilities of $561.4 million, resulting in total equity of $429.4 million. Long-term debt stands at $532.2 million, substantially exceeding the cash and equivalents balance of $3.3 million. This negative net cash position is flagged as a key risk, indicating limited immediate liquidity buffers against debt obligations. The company generates operating cash flow of $56.4 million, which serves as the primary source for debt service and potential capital returns, though the high debt load constrains financial flexibility.

    Profitability metrics indicate modest returns on capital, with a return on equity of 1.19% and a return on assets of 0.51%. Net income for the latest period was $5.1 million on revenue of $121.2 million. Without cohort median data for direct comparison, these returns must be evaluated against the broader Health Care REITs industry context, where leverage typically amplifies equity returns but also increases sensitivity to interest rate fluctuations and occupancy rates. The low net income relative to total assets suggests that a significant portion of revenue is consumed by interest expenses and depreciation, consistent with the high debt-to-equity profile.

    The company’s operational structure is supported by a network of subsidiaries, including Community Healthcare OP, LP and various state-specific LLCs such as CHCT Alabama, LLC and CHCT California, LLC. This subsidiary structure facilitates the management of geographically dispersed skilled nursing facilities. While specific revenue breakdowns by segment or geography are not provided in the current data, the presence of multiple state-level entities implies a diversified geographic footprint across the United States, which may mitigate localized economic risks but also requires complex operational oversight.

    Growth trajectory analysis is limited by the absence of historical period data in the current input. Consequently, trends in revenue and net income over the past five years or eight quarters cannot be quantified. The current revenue figure of $121.2 million represents the latest normalized period, but without prior period comparisons, the direction and velocity of growth remain indeterminate from the available data.

    Risk assessment highlights medium liquidity risk and low dilution risk. The primary concern is the negative net cash position, which exposes the company to refinancing risks and potential covenant breaches if operating cash flows decline. The low dilution risk suggests that the company is not currently issuing significant new equity, preserving existing shareholder value from dilution, although the high debt levels may limit future acquisition capacity without additional financing.

    Recent observations include internal reconciler events related to analysis job queuing, which do not represent material business developments. The IR observations confirm the corporate structure through EDGAR filings, validating the subsidiary relationships but offering no new strategic insights. No significant news events, filing observations, or transcript observations were provided that would indicate recent strategic shifts, mergers, or operational changes.

    Key takeaways
    • High leverage with a debt-to-equity ratio of 1.24 and negative net cash position creates medium liquidity risk.
    • Modest profitability with 1.19% ROE and 0.51% ROA reflects the capital-intensive nature of the REIT model.
    • Operating cash flow of $56.4 million provides a buffer for debt service but is constrained by high interest obligations.
    • Low dilution risk indicates stable share count, with 28.5 million basic and diluted shares outstanding.
    • Geographic diversification is implied through multiple state-level subsidiaries, though specific revenue mix is undisclosed.
    • Lack of historical data prevents assessment of growth trends, limiting the ability to evaluate momentum.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $18,82
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $429.4M
    Net cash
    -$528.9M
    Current ratio
    Debt / equity
    1.2
    ROA
    0.5%
    ROE
    1.2%
    Cash conversion
    1106.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships48 disclosed relationships · 2 types · extracted from filings & disclosures
    Customers3
    Davita IncDVA.OCustomer95%Source ↗
    Fresenius SE & Co. KGaAFRE.DECustomer95%Source ↗
    Subsidiaries45
    EX21:037071050e03EX21:037071050e03Subsidiarie97%
    EX21:04cb23ec8561EX21:04cb23ec8561Subsidiarie97%
    EX21:09aebb0fa9d9EX21:09aebb0fa9d9Subsidiarie97%
    EX21:1aa358d9ead7EX21:1aa358d9ead7Subsidiarie97%
    EX21:30104928cd1cEX21:30104928cd1cSubsidiarie97%
    EX21:33fba9e0395dEX21:33fba9e0395dSubsidiarie97%
    EX21:4c1af0ada787EX21:4c1af0ada787Subsidiarie97%
    EX21:4ed5da842aaaEX21:4ed5da842aaaSubsidiarie97%
    EX21:5d9be64fa8a2EX21:5d9be64fa8a2Subsidiarie97%
    EX21:648d8218f92fEX21:648d8218f92fSubsidiarie97%
    EX21:65e17203c982EX21:65e17203c982Subsidiarie97%
    EX21:697f6400eb41EX21:697f6400eb41Subsidiarie97%
    EX21:7351ed3731f7EX21:7351ed3731f7Subsidiarie97%
    EX21:743ab8d687faEX21:743ab8d687faSubsidiarie97%
    EX21:7e9cda326e5bEX21:7e9cda326e5bSubsidiarie97%
    EX21:82e9d55fd38cEX21:82e9d55fd38cSubsidiarie97%
    EX21:86e22d1730b2EX21:86e22d1730b2Subsidiarie97%
    EX21:8c0ff5fb5f10EX21:8c0ff5fb5f10Subsidiarie97%
    EX21:94c82470cffeEX21:94c82470cffeSubsidiarie97%
    EX21:94e5c7b87b5eEX21:94e5c7b87b5eSubsidiarie97%
    EX21:993c81f629a1EX21:993c81f629a1Subsidiarie97%
    EX21:9bf461b0d32fEX21:9bf461b0d32fSubsidiarie97%
    EX21:9d388d133d77EX21:9d388d133d77Subsidiarie97%
    EX21:9fb44a63c8f1EX21:9fb44a63c8f1Subsidiarie97%
    EX21:a99bedf55ac5EX21:a99bedf55ac5Subsidiarie97%
    EX21:aa340246381dEX21:aa340246381dSubsidiarie97%
    EX21:ac7a972af050EX21:ac7a972af050Subsidiarie97%
    EX21:afd4c4c01c6eEX21:afd4c4c01c6eSubsidiarie97%
    EX21:b23e192a729cEX21:b23e192a729cSubsidiarie97%
    EX21:b599c3bbbf98EX21:b599c3bbbf98Subsidiarie97%
    EX21:cafc8582d2ebEX21:cafc8582d2ebSubsidiarie97%
    EX21:cff81e710bcfEX21:cff81e710bcfSubsidiarie97%
    EX21:d130f7fd8e8aEX21:d130f7fd8e8aSubsidiarie97%
    EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
    EX21:d508930f5ceaEX21:d508930f5ceaSubsidiarie97%
    EX21:d781f43219f9EX21:d781f43219f9Subsidiarie97%
    EX21:dee1eb2c1f47EX21:dee1eb2c1f47Subsidiarie97%
    EX21:e17569eb8445EX21:e17569eb8445Subsidiarie97%
    EX21:e4950fdc15c0EX21:e4950fdc15c0Subsidiarie97%
    EX21:e6ca955d0323EX21:e6ca955d0323Subsidiarie97%
    EX21:edb3b0cc6dcdEX21:edb3b0cc6dcdSubsidiarie97%
    EX21:eeeff5b6add6EX21:eeeff5b6add6Subsidiarie97%
    EX21:ef5c522b395dEX21:ef5c522b395dSubsidiarie97%
    EX21:ef9590827db4EX21:ef9590827db4Subsidiarie97%
    EX21:f87deb171456EX21:f87deb171456Subsidiarie97%

    Supply chain

    Vendors → CHCT ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSCHCTCHCTCommunity Healthcare Trust Inc48 entitiesDavita IncOil & Gas Exploration & USFresenius SE & Co. KGaDETenet Healthcare CorpMedical Equipment & SuppUS
    3 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy1
    Buy2
    Hold2
    Sell0
    Strong sell0
    12-month price target$19,40 · Median $20,00
    Low $17,00High $20,00
    Operating income · consensus37,0M USD
    EPS surprise
    −82,6 %
    reported vs consensus · miss
    Revenue surprise
    −5,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$17,00
    Mean$19,40
    Median$20,00
    High$20,00
    Spot$18,82
    +3.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Return On Assets
      net_income / total_assets
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    Source documents
    • Community Healthcare Trust Inc Market data — financials · 2026-07-28
    • reconciler_enqueue (reconciler) on CHCT.K · 2026-07-28
    • Community Healthcare Trust Inc HA canonical relationships · 2026-07-28

    Ownership & reference

    Top holders

    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$13M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$109M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$5M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$13M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$8M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$3M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$6M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$6M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$4M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$12M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$46M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$4M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$12M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$3M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$1M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$3M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • David H. DupuyPresident, Chief Executive Officer, Director

    Insider activity

    Net buying1 buys · 0 sellsnet $59K8 insiders · last 365d
    • Stach Leigh AnnExecutive Vice President & CAO · Common StockOther 8 589 · 2026-07-30
    • Monroe William G. IVExecutive Vice President & CFO · Common StockOther 10 163 · 2026-07-30
    • Dupuy David H.Director, CEO and President · Common StockOther 15 573 · 2026-07-30
    • Dupuy David H.Director, CEO and President · Common StockOther 2 556 @ $17,83$46K · 2026-06-30
    • Stach Leigh AnnExecutive Vice President & CAO · Common StockOther 1 435 @ $17,83$26K · 2026-06-30
    • Monroe William G. IVExecutive Vice President & CFO · Common StockOther 1 630 @ $17,83$29K · 2026-06-30
    • Gardner AlanDirector · Common StockOther 7 661 @ $17,23$132K · 2026-05-21
    • GULMI CLAIRE MDirector · Common StockOther 7 661 @ $17,23$132K · 2026-05-21
    • Van Horn R. LawrenceDirector · Common StockOther 7 661 @ $17,23$132K · 2026-05-21
    • Cotman CathrineDirector · Common StockOther 6 036 @ $17,23$104K · 2026-05-21
    • Hensley Robert ZDirector · Common StockOther 6 036 @ $17,23$104K · 2026-05-21
    • Cotman CathrineDirector · Common StockOther 6 222 · 2026-05-07
    • GULMI CLAIRE MDirector · Common StockOther 6 222 · 2026-05-07
    • Hensley Robert ZDirector · Common StockOther 6 222 · 2026-05-07
    • Gardner AlanDirector · Common StockOther 6 222 · 2026-05-07
    • Van Horn R. LawrenceDirector · Common StockOther 6 222 · 2026-05-07
    • Dupuy David H.Director, CEO and President · Common StockOther 29 941 @ $16,70$500K · 2026-01-15
    • Stach Leigh AnnExecutive Vice President & CAO · Common StockOther 4 643 @ $16,70$78K · 2026-01-15
    • Monroe William G. IVExecutive Vice President & CFO · Common StockOther 29 605 @ $16,70$494K · 2026-01-15
    • Stach Leigh AnnExecutive Vice President & CAO · Common StockOther 17 889 @ $16,70$299K · 2026-01-15
    • GULMI CLAIRE MDirector · Common StockOther 197 @ $14,58$3K · 2025-11-21
    • Cotman CathrineDirector · Common StockBought 4 000 @ $14,66$59K · 2025-11-04
    • GULMI CLAIRE MDirector · Common StockOther 187 @ $14,76$3K · 2025-08-22
    • Dupuy David H.Director, CEO and President · Common StockOther 29 338 @ $15,85$465K · 2025-08-07
    • Monroe William G. IVExecutive Vice President & CFO · Common StockOther 29 009 @ $15,85$460K · 2025-08-07

    Short positioning

    962.3Kshares short+27.0% vs prior
    5.09days to cover
    73.3%short of daily vol
    72fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CHCT.KCanonical
    NYSE · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    CHCTDVA.OFRE.DETHC.OEX21:037EX21:04cEX21:09aEX21:1aaEX21:301EX21:33fEX21:4c1Health Care RE
    This companySectorCustomersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Shares outstanding (annual): 28.47MUnknown
    • Net income (annual): USD 5.1MUnknown
    • EPS (basic) (annual): USD-PER-SHARES 0Unknown
    • Total operating expenses (annual): USD 92.26MUnknown
    • Total liabilities (annual): USD 561.37MUnknown
    • Shareholders' equity (annual): USD 429.39MUnknown
    • Revenue (annual): USD 121.19MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 0Unknown
    • Total assets (annual): USD 990.76MUnknown
    • Operating cash flow (annual): USD 56.43MUnknown
    • Cash & equivalents (annual): USD 3.34MUnknown
    • Long-term debt (annual): USD 532.2MUnknown
    • Cash & equivalents (annual): USD 4.38MUnknown
    • Operating cash flow (annual): USD 58.88MUnknown
    • Shareholders' equity (annual): USD 475.96MUnknown
    • Total liabilities (annual): USD 516.6MUnknown
    • Revenue (annual): USD 115.79MUnknown
    • Net income (annual): USD -3.18MUnknown
    • Long-term debt (annual): USD 485.95MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES -0Unknown
    • Shares outstanding (annual): 28.24MUnknown
    • EPS (basic) (annual): USD-PER-SHARES -0Unknown
    • Total assets (annual): USD 992.56MUnknown
    • Total operating expenses (annual): USD 84.67MUnknown
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-04 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-08-04EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-06-30INSIDERMonroe William G. IV transacted 1.6k sh — Executive Vice President & CFO ~$29k
    2026-06-30INSIDERDupuy David H. transacted 2.6k sh — Director, CEO and President ~$46k
    2026-06-30INSIDERStach Leigh Ann transacted 1.4k sh — Executive Vice President & CAO ~$26k
    2026-05-21 00:00 UTCINSIDER10 insider transactions — 2026-05 · net buy $604k
    2026-05-21 00:00 UTCINSIDER10 insider transactions — 2026-05 · net buy $604k
    2026-05-21INSIDERGardner Alan transacted 7.7k sh — Director ~$132k
    2026-05-21INSIDERGULMI CLAIRE M transacted 7.7k sh — Director ~$132k
    2026-05-21INSIDERVan Horn R. Lawrence transacted 7.7k sh — Director ~$132k
    2026-05-21INSIDERCotman Cathrine transacted 6.0k sh — Director ~$104k
    2026-05-21INSIDERHensley Robert Z transacted 6.0k sh — Director ~$104k
    2026-05-07FILING8-K filing →
    2026-05-07INSIDERCotman Cathrine transacted 6.2k sh — Director
    2026-05-07INSIDERGULMI CLAIRE M transacted 6.2k sh — Director
    2026-05-07INSIDERHensley Robert Z transacted 6.2k sh — Director
    2026-05-07INSIDERGardner Alan transacted 6.2k sh — Director
    2026-05-07INSIDERVan Horn R. Lawrence transacted 6.2k sh — Director
    2026-05-05FILING10-Q filing →
    2026-05-05FILING8-K filing →
    2026-03-12FILINGDEF 14A filing →
    2026-02-17FILING8-K filing →
    2026-02-17FILING10-K filing →
    2026-01-15 00:00 UTCINSIDER4 insider transactions — 2026-01 · net buy $1.2M
    2026-01-15 00:00 UTCINSIDER4 insider transactions — 2026-01 · net buy $1.2M
    2026-01-15INSIDERDupuy David H. transacted 29.9k sh — Director, CEO and President ~$500k
    2026-01-15INSIDERStach Leigh Ann transacted 4.6k sh — Executive Vice President & CAO ~$78k
    2026-01-15INSIDERMonroe William G. IV transacted 29.6k sh — Executive Vice President & CFO ~$494k
    2026-01-15INSIDERStach Leigh Ann transacted 17.9k sh — Executive Vice President & CAO ~$299k
    2026-01-09FILINGFORM 8-K →
    2025-11-21 00:00 UTCINSIDER2 insider transactions — 2025-11
    2025-11-21 00:00 UTCINSIDER2 insider transactions — 2025-11
    2025-11-21INSIDERGULMI CLAIRE M transacted 197 sh — Director ~$3k
    2025-11-04INSIDERCotman Cathrine bought 4.0k sh — Director ~$59k
    2025-10-28FILING8-K filing →
    2025-10-28FILING10-Q filing →
    2025-08-22 00:00 UTCINSIDER4 insider transactions — 2025-08 · net buy $1.2M
    2025-08-22 00:00 UTCINSIDER4 insider transactions — 2025-08 · net buy $1.2M
    2025-08-22INSIDERGULMI CLAIRE M transacted 187 sh — Director ~$3k
    Showing the 40 most recent of 46 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage